论文信息 - P2.06-007 A Phase 1/2 Trial of the Oral EGFR/HER2 Inhibitor AP32788 in Non–Small Cell Lung Cancer (NSCLC): Topic: Phase I/II Trials - 字舞流文

P2.06-007 A Phase 1/2 Trial of the Oral EGFR/HER2 Inhibitor AP32788 in Non–Small Cell Lung Cancer (NSCLC): Topic: Phase I/II Trials

P. Jänne | J. Neal | D. Costa | R. Doebele | W. Reichmann | L. Horn | A. Spira | D. Kerstein | Z. Piotrowska | Shuanglian Li